Why This Matters for Your Career
Synthonics is hiring 1 role related to this product
Company
Synthonics
VA - Blacksburg
OZANIMOD (ozanimod) by Synthonics is 1-phosphate (s1p) receptor modulator that binds with high affinity to s1p receptors 1 and 5.
Drug data last refreshed 1mo ago
1-phosphate (S1P) receptor modulator that binds with high affinity to S1P receptors 1 and 5. Ozanimod blocks the capacity of lymphocytes to egress from lymph nodes, reducing the number of lymphocytes in peripheral blood. Ozanimod has minimal or no activity on S1P 2 , S1P 3 , and S1P 4 . The…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
A Lactation Study in Women Receiving Treatment With Ozanimod
Ozanimod in Patients With Alzheimer's Disease
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Worked on OZANIMOD at Synthonics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Synthonics is hiring 1 role related to this product